Australia markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
289.45-2.43 (-0.83%)
At close: 04:00PM EDT
290.09 +0.64 (+0.22%)
Pre-market: 08:04AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
403,815
434,215
470,783
662,205
-
Other short-term investments
1,203,327
1,356,457
399,135
328,913
-
Total cash
1,607,142
1,790,672
869,918
991,118
-
Net receivables
489,017
494,645
423,537
419,424
-
Inventory
780,517
719,316
572,239
622,253
-
Other current assets
26,054
23,604
10,089
10,859
-
Total current assets
3,048,330
3,157,976
1,990,479
2,139,835
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,790,430
1,688,952
1,718,277
1,654,897
-
Accumulated depreciation
-1,066,700
-1,009,400
-1,001,840
-961,390
-
Net property, plant and equipment
723,730
679,552
716,437
693,507
-
Equity and other investments
7,698,070
8,830,892
14,387,006
9,561,140
-
Goodwill
413,600
406,500
347,300
291,900
-
Intangible assets
320,500
332,100
253,900
199,500
-
Other long-term assets
94,850
94,599
104,189
86,723
-
Total non-current assets
9,250,750
10,343,643
15,808,832
10,832,770
-
Total assets
12,299,070
13,501,666
17,799,393
12,972,618
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
486
465
489
1,300
-
Accounts payable
144,625
135,041
141,941
139,451
-
Taxes payable
-
11,929
10,319
23,282
8,763
Accrued liabilities
139,929
194,790
276,986
222,875
-
Deferred revenues
-
52,211
50,852
42,468
33,735
Other current liabilities
161,621
169,648
127,936
131,100
-
Total current liabilities
522,799
568,708
680,938
631,536
-
Non-current liabilities
Long-term debt
1,199,100
1,197,700
10,514
1,300
-
Deferred tax liabilities
1,475,495
1,770,481
3,064,576
2,076,785
-
Other long-term liabilities
195,065
195,928
182,191
196,929
-
Total non-current liabilities
3,035,138
3,317,706
3,433,219
2,461,142
-
Total liabilities
3,557,937
3,886,414
4,114,157
3,092,678
-
Stockholders' equity
Common stock
3
3
3
3
-
Retained earnings
9,260,629
9,898,203
13,525,343
9,268,012
-
Accumulated other comprehensive income
-336,038
-466,822
-175,553
282,456
-
Total stockholders' equity
8,741,133
9,615,252
13,685,236
9,879,940
-
Total liabilities and stockholders' equity
12,299,070
13,501,666
17,799,393
12,972,618
-